Weiss, J. M., Guérin, M. V., Regnier, F., Renault, G., Galy-Fauroux, I., Vimeux, L., . . . Bercovici, N. (2017). The STING agonist DMXAA triggers a cooperation between T lymphocytes and myeloid cells that leads to tumor regression. Oncoimmunology.
Chicago-стиль цитированияWeiss, Julia M., et al. "The STING Agonist DMXAA Triggers a Cooperation between T Lymphocytes and Myeloid Cells That Leads to Tumor Regression." Oncoimmunology 2017.
MLA-цитированиеWeiss, Julia M., et al. "The STING Agonist DMXAA Triggers a Cooperation between T Lymphocytes and Myeloid Cells That Leads to Tumor Regression." Oncoimmunology 2017.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.